Cargando…
Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes
Type 1 diabetes (T1D) is characterized by insulin deficiency resulting from the selective destruction of pancreatic β-cells by self-reactive T cells. Recent evidence demonstrates that innate immune responses substantially contribute to the pathogenesis of T1D, as they represent a first line of respo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881863/ https://www.ncbi.nlm.nih.gov/pubmed/33472941 http://dx.doi.org/10.2337/dbi20-0026 |
_version_ | 1783650961962565632 |
---|---|
author | Petrelli, Alessandra Atkinson, Mark A. Pietropaolo, Massimo Giannoukakis, Nick |
author_facet | Petrelli, Alessandra Atkinson, Mark A. Pietropaolo, Massimo Giannoukakis, Nick |
author_sort | Petrelli, Alessandra |
collection | PubMed |
description | Type 1 diabetes (T1D) is characterized by insulin deficiency resulting from the selective destruction of pancreatic β-cells by self-reactive T cells. Recent evidence demonstrates that innate immune responses substantially contribute to the pathogenesis of T1D, as they represent a first line of response to danger/damage signals. Here we discuss evidence on how, in a relapsing-remitting pattern, pancreas remodeling, diet, microbiota, gut permeability, and viral/bacterial infections induce the accumulation of leukocytes of the innate arm of the immune system throughout the pancreas. The subsequent acquisition and presentation of endocrine and exocrine antigens to the adaptive arm of the immune system results in a chronic progression of pancreatic damage. This process provides for the generation of self-reactive T-cell responses; however, the relative weight that genetic and environmental factors have on the etiopathogenesis of T1D is endotype imprinted and patient specific. With this Perspectives in Diabetes, our goal is to encourage the scientific community to rethink mechanisms underlying T1D pathogenesis and to consider therapeutic approaches that focus on these processes in intervention trials within new-onset disease as well as in efforts seeking the disorder’s prevention in individuals at high risk. |
format | Online Article Text |
id | pubmed-7881863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-78818632021-02-22 Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes Petrelli, Alessandra Atkinson, Mark A. Pietropaolo, Massimo Giannoukakis, Nick Diabetes Perspectives in Diabetes Type 1 diabetes (T1D) is characterized by insulin deficiency resulting from the selective destruction of pancreatic β-cells by self-reactive T cells. Recent evidence demonstrates that innate immune responses substantially contribute to the pathogenesis of T1D, as they represent a first line of response to danger/damage signals. Here we discuss evidence on how, in a relapsing-remitting pattern, pancreas remodeling, diet, microbiota, gut permeability, and viral/bacterial infections induce the accumulation of leukocytes of the innate arm of the immune system throughout the pancreas. The subsequent acquisition and presentation of endocrine and exocrine antigens to the adaptive arm of the immune system results in a chronic progression of pancreatic damage. This process provides for the generation of self-reactive T-cell responses; however, the relative weight that genetic and environmental factors have on the etiopathogenesis of T1D is endotype imprinted and patient specific. With this Perspectives in Diabetes, our goal is to encourage the scientific community to rethink mechanisms underlying T1D pathogenesis and to consider therapeutic approaches that focus on these processes in intervention trials within new-onset disease as well as in efforts seeking the disorder’s prevention in individuals at high risk. American Diabetes Association 2021-02 2021-01-14 /pmc/articles/PMC7881863/ /pubmed/33472941 http://dx.doi.org/10.2337/dbi20-0026 Text en © 2021 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
spellingShingle | Perspectives in Diabetes Petrelli, Alessandra Atkinson, Mark A. Pietropaolo, Massimo Giannoukakis, Nick Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes |
title | Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes |
title_full | Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes |
title_fullStr | Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes |
title_full_unstemmed | Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes |
title_short | Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes |
title_sort | modulation of leukocytes of the innate arm of the immune system as a potential approach to prevent the onset and progression of type 1 diabetes |
topic | Perspectives in Diabetes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881863/ https://www.ncbi.nlm.nih.gov/pubmed/33472941 http://dx.doi.org/10.2337/dbi20-0026 |
work_keys_str_mv | AT petrellialessandra modulationofleukocytesoftheinnatearmoftheimmunesystemasapotentialapproachtopreventtheonsetandprogressionoftype1diabetes AT atkinsonmarka modulationofleukocytesoftheinnatearmoftheimmunesystemasapotentialapproachtopreventtheonsetandprogressionoftype1diabetes AT pietropaolomassimo modulationofleukocytesoftheinnatearmoftheimmunesystemasapotentialapproachtopreventtheonsetandprogressionoftype1diabetes AT giannoukakisnick modulationofleukocytesoftheinnatearmoftheimmunesystemasapotentialapproachtopreventtheonsetandprogressionoftype1diabetes |